Keck School of Medicine of USC

Keck School of Medicine of USC

We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.

 

2021 Updates on HER2+ MBC: Tucatinib Combo and HRQoL in Brain Mets, Margetuximab+Chemo vs. Tras+Chemo, Subcutaneous Formulations

121 views
February 5, 2021
Comments 0
Login to view comments. Click here to Login